GSK CH’s current annual sales is about ₹4,200 crore.The e-commerce giant's sustainabilty quotient got a boost recently, when it announced 100% elimination of ...Every cricket lover knows NatWest, thanks to the keenly followed One Day International series. In case you can’t find any email from our side, please check the spam folder.The company was “clear all along that the most logical structure for the India leg of the deal is the merger of GSK Consumer Healthcare with HUL," said the third person, highlighting the factors that favoured HUL.
You will never reach the market price for an Indian company with this model because they have longer growth horizons," the second person cited before said. The deal values the total business at ₹31,700 crore. The potential deal is a win-win for both the parties as the acquisition of strong brands in the HFD category would boost HUL’s food business by 900 bps to 27 per cent from the current 18 per cent of sales with sustainable profitable growth, while the deal is positive for shareholders of GSK Consumer Healthcare as they will get a better value under the share swap arrangement,” said Kaustubh Pawaskar of BNP Paribas.
“There were three major criteria—valuation, certainty and ability to close the deal quickly and a distribution arrangement for the rest of the products that are not being sold. Photo: Bloomberg How Hindustan Unilever clinched GSK Consumer Healthcare deal “It was clear from the start that this was a asset for strategic investors only. Together, they employ 17 lakh ...The deal will help HUL strengthen its food and refreshment business by entering the health food drinks (HFD) that has witnessed the entry of several global and Indian players in the last few years. "“The deal structure shows that all-stock mergers are emerging as the preferred route for high-value and high-multiple M&A transactions in India, given the fact that most buyers are unwilling to raise debt and leverage themselves more at a time when credit environment is tight and to also insulate them for mismatch in earning cycle, where payback periods would be very high," said Mahesh Singhi, founder and managing director of transaction advisory firm Singhi Advisors.“Several bidders were offering cash offers simply because they did not have a merger option," said the second person cited earlier, requesting anonymity. The deal values the total business at ₹31,700 crore.The Indian wearables market in 2019 saw a record year of growth, which research firm IDC said had grown 177 ...“This is a strategic and transformative move for us and we believe that GSK CH has some great iconic brands in the health and wellness space, and that will add significantly to our portfolio. “This was particularly the case with financial investors such as PE firms and even some of the strategic players. GSK is expected to sell these shares subsequently, HUL’s Chairman and MD Sanjeev Mehta said at a press conference in Mumbai.